Neuroendocrine Control of Pituitary Function in Extrapiramidal Disorders
The purpose of this study was to reconsider the functional status of the hypothalamus-pituitary axis in diseases of the extrapyramidal system. The theme of the paper is behavior of the secretion of growth hormone (GH), thyroid-stimulating hormone (TSH), and prolactin (PRL), particularly in Huntington’s disease (HD) and Parkinson’s disease (PD). The choice of these hormones derives from the fact that their secretion is under a dopaminergic control1 and that this latter function is notedly involved in the pathologies under examination.
KeywordsGrowth Hormone Growth Hormone Response Parkinsonian Patient Basal Growth Hormone Level Control Growth Hormone Secretion
Unable to display preview. Download preview PDF.
- 1.E. E. Miiller, G. Nistico and U. Scapagnini, “Neurotransmitters and Anterior Pituitary Function,” Academic Press, New York (1978).Google Scholar
- 2.G. W. Bruyn, Huntington’s chorea, history, clinical and laboratory synopsis, in: “Handbook of Clinical Neurology,” vol. 6, P. J. Vinken and G. W. Bruyn, eds., North-Holland, Amsterdam (1968).Google Scholar
- 3.E. D. Bird, Neuroendocrine changes in Huntington’s disease — An overview, Adv Neurol 23:291 (1979).Google Scholar
- 8.T. A. Caraceni, E. A. Parati, P. M. Giovannini et al., Neuroendocrinological findings in untreated huntingtonian patients, Arch Neurol in press (1983).Google Scholar
- 10.E. E. Miiller, E. A. Parati, D. Cocchi, D. Zanardi and T. Caraceni, Dopaminergic drugs on growth hormone and prolactin secretion in Huntington’s disease, Adv Neurol 23:319 (1979).Google Scholar
- 24.A. Polleri, P. Masturzo, G. Muriaido et al., Chronobiology of prolactin secretion: a marker in physiology and pathology, in: “Central and Peripheral Regulation of Prolactin Function,” R. M. MacLeod and U. Scapagnini, eds., Raven Press, New York (1980).Google Scholar